I Wish I Were Far From the Madding Crowd

September 8, 2010

Protecting ourselves from harmful chemical exposures: Your chance for input

National Conversation on Public Health and Chemical Exposures

http://www.atsdr.cdc.gov/nationalconversation/

Project goals – http://www.atsdr.cdc.gov/nationalconversation/accomplish.html

The National Conversation’s vision is to ensure that chemicals are used and managed in safe and healthy ways for all people.  The goal of the National Conversation is to develop an action agenda—clear, achievable recommendations—that will help government agencies and other organizations strengthen their efforts to protect the public from harmful chemical exposures.  The action agenda will help our nation identify better ways to

  • Collect information about chemical use, people who are exposed, and the levels at which they are exposed.
  • Understand how chemicals affect people’s health.
  • Use policies and practices that tell us about risks, how to reduce harmful exposures, and how to create and use safe chemicals.
  • Prevent, prepare for, and respond to chemical-related emergencies.
  • Protect all communities from harmful chemical exposures.
  • Create a well-informed public and health care provider network to help people understand chemical exposure risks.
  • Involve the public in government decision making.
  • Encourage teamwork among partner groups and agencies.

To help with this, work groups were formed last year to discuss six cross-cutting issues.  After receiving public input, they have released draft reports for public comment.  You can download the report for each work group from the pages linked to below and submit your comments via those pages, e-mail or other means listed there.

CDC and ATSDR are working with RESOLVE, a non-profit facilitation group that will compile the comments, as well as other organizations such as the American Public Health Association, Association of State and Territorial Health Officials, and National Association of County and City Health Officials.

Advertisements

March 21, 2010

Sound advice to companies on endocrine disruptors

Found a post on endocrine disruptors that advises companies on steps they should be taking to deal with endocrine disruptors now.  You’re probably thinking what I thought when I first saw the post, “Yeah, right.”

I was pleasantly surprised.  It’s heartening to see an investment manager taking an enlightened  position like this.

The Chemicals That Should Be on Your Radar … but Probably Aren’t

By Richard Liroff – Published February 25, 2010
[This post is a follow up to Liroff’s earlier article “What Does the FDA’s BPA Decision Mean for Companies?” on GreenBiz.com.]

Liroff notes:

As a class, [endocrine disruptors (EDs)] can have profound and unparalleled impacts on families, communities and businesses because of their possible links to learning disabilities, selected cancers, reproductive disorders, diabetes and other health disorders.

Systematically identifying EDs, substituting safer substances and product designs, and reducing exposures promise sizeable payoffs from reduced health care burdens and enhanced employee productivity. Such actions help align consumer-facing companies in particular with consumers’ concerns about involuntary exposures to toxic chemicals in daily living.

Liroff lists several recent developments in public awareness regarding endocrine disruptors, describes what endocrine disruptors are and how they can affect health, and offers the following advice to chemical companies regarding endocrine disruptors:

1. Get educated.

He provides links to European, U.S. EPA, and NIEHS endocrine disruption websites as well as the The Endocrine Disruption Exchange (TEDX) list of resources.  (A very nice list!)

2. Make sure corporate science staff stay current.

Why the Adage ‘the Dose Makes the Poison’ Can Be Toxic to Corporate Chemicals Policy

Heed the advice of NIEHS’s Dr. Linda Birnbaum: “[T]he timing, as well as the dose, makes the poison.” The American Chemical Society, in a newly published statement on endocrine disruptors, echoes this view: “A large and growing body of environmental health literature shows that endocrine disrupting substances … do not fit the central tenet of regulatory toxicology, namely, that the ‘dose makes the poison.'”

3. Know the chemicals in your products and supply chain.

4. Take action. Join the leading edge companies who are actively screening their chemical inventories for endocrine disruptors and are taking steps to lower toxicity via safer chemical substitutes or designs….

[A] proactive approach of analysis and substitution, and responding to early warning signals, is more likely to buttress consumer confidence in your brand than defensive posturing that reflexively asserts “more research is needed” or “no cause-effect relationships have been shown.”

Richard A. Liroff, Ph.D., is founder and director of the Investor Environmental Health Network (IEHN). IEHN is a collaboration of investment managers that advocates for safer corporate chemicals policies to grow long-term shareholder value and reduce financial and reputational risks to companies. The business case for corporate safer chemicals policies, a list of shareholder resolutions on safer chemicals policies, and a roster of participants can be found on the IEHN website, www.iehn.org. Disclosure: Liroff serves as Vice-Chair of the Board of Directors of The Endocrine Disruption Exchange and served on the priority-setting work group of EPA’s Endocrine Disruption Screening and Testing Advisory Committee.

Blog at WordPress.com.